Regeneron: Antibody Cocktail 100 Percent Effective Against Symptomatic COVID-19 Infections From The Epoch Times by BY ZACHARY STIEBER January 26, 2021 Regeneron Pharmaceuticals on Tuesday announced that a phase 3 trial still in progress of an antibody cocktail has shown a 100 percent prevention of symptomatic COVID-19 infections. Interim results also show approximately 50 percent…
